Hylambatin
Hylambatin, a tachykinin, increases both plasma glucose and plasma insulin, whereas the secretion of glucagon was not affected. Hylambatin can be used in diabetes research[1].
Product Specifications
CAS Number
80890-46-6
UNSPSC
12352209
Target
Biochemical Assay Reagents
Type
Peptides
Related Pathways
Others
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hylambatin.html
Solubility
10 mM in DMSO
Smiles
O=C(N1[C@@H](CCC1)C(N2[C@@H](CCC2)C(N[C@@H](CC(O)=O)C(N3[C@@H](CCC3)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC4=CC=CC=C4)C(N[C@@H](CC5=CC=C(C=C5)O)C(NCC(N[C@@H](CCSC)C(N[C@@H](CCSC)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(O)=O)N
Molecular Formula
C63H90N16O19S2
Molecular Weight
1439.61
References & Citations
[1]Güllner HG, et al. Hylambatin, a structurally unique tachykinin: effects on insulin and glucagon secretion. Arch Int Pharmacodyn Ther. 1984 Dec;272 (2) :304-9.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog